Orbimed Advisors LLC’s Enliven Therapeutics Inc Position
Does Orbimed Advisors LLC own Enliven Therapeutics Inc (ELVN)? Yes — 7.96M shares worth $312M (+6.18% of its 13F portfolio) as of Q1 2026.
Position Value
$312M
Q1 2026
Shares
7.96M
% of Portfolio
+6.18%
Quarters Held
13
currently held
Position History ELVN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 7.96M | $312M | +6.18% |
| Q4 2025 | 7.96M | $123M | +2.50% |
| Q3 2025 | 7.96M | $163M | +3.83% |
| Q2 2025 | 7.96M | $160M | +3.99% |
| Q1 2025 | 7.96M | $157M | +3.73% |
| Q4 2024 | 7.96M | $179M | +3.68% |
| Q3 2024 | 7.96M | $203M | +3.69% |
| Q2 2024 | 7.96M | $186M | +3.67% |
| Q1 2024 | 9.00M | $158M | +2.90% |
| Q4 2023 | 9.00M | $125M | +2.49% |
| Q3 2023 | 9.00M | $123M | +2.61% |
| Q2 2023 | 9.00M | $184M | +3.33% |
| Q1 2023 | 9.00M | $197M | +3.87% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of ELVN.